<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="343050">
  <stage>Registered</stage>
  <submitdate>10/06/2011</submitdate>
  <approvaldate>10/06/2011</approvaldate>
  <actrnumber>ACTRN12611000604909</actrnumber>
  <trial_identification>
    <studytitle>Does cabergoline improve cognition and attention more than placebo in healthy volunteers and what does this tell us about mechanisms of attention?</studytitle>
    <scientifictitle>A randomised controlled trial comparing the effects of cabergoline vs placebo on executive control in healthy male volunteers</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Executive control in healthy volunteers</healthcondition>
    <conditioncode>
      <conditioncode1>Mental Health</conditioncode1>
      <conditioncode2>Studies of normal psychology, cognitive function and behaviour</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Neurological</conditioncode1>
      <conditioncode2>Studies of the normal brain and nervous system</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>A single dose of cabergoline (oral capsule containing 1.25mg)
(1-2 week washout period between conditions)</interventions>
    <comparator>A single dose of an identical looking placebo capsule
(1-2 week washout period between conditions)</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Response inhibition measured using the Stop Signal Task</outcome>
      <timepoint>1 hour following administration of capsule</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Error awareness using the Error Awareness Task (EAT)</outcome>
      <timepoint>1 hour following administration of capsule</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Spatial attention measured with two tasks, the Attention-Competition Task and the Grey-Scales Task</outcome>
      <timepoint>1 hour following administration of capsule</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Healthy volunteers
Aged 18 -40 years 
Male</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>40</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Males</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Current psychiatric or neurological illness
Current use of psychotropic medication
CUrrent substance use or dependence
Medical illness that is a contraindication for cabergoline use</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate>20/06/2011</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>24</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>The University of Queensland</primarysponsorname>
    <primarysponsoraddress>The Queensland Brain Institute
Building #79, Upland Rd
The University of Queensland
St Lucia QLD 4072</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>The Queensland Brain Institute</fundingname>
      <fundingaddress>The Queensland Brain Institute
Building #79, Upland Rd
The University of Queensland
St Lucia QLD 4072</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Cognitive control and spatial attention are skills that allows us to interpret and act in our environment. Although these skills are important, little is understood about the neurochemical processes that are important to cognitive control and spatial attention. This study will allow us to assess the importance of different brain chemicals in contributing to spatial attention and cognitive function.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Angela Dean</name>
      <address>The Queensland Brain Institute
Building #79, Upland Rd
The University of Queensland
St Lucia QLD 4072</address>
      <phone>+61 7 3346 3325</phone>
      <fax />
      <email>a.dean@uq.edu.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Angela Dean</name>
      <address>The Queensland Brain Institute
Building #79, Upland Rd
The University of Queensland
St Lucia QLD 4072</address>
      <phone>+61 7 3346 3325</phone>
      <fax />
      <email>a.dean@uq.edu.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>